Table 4.
Comparisons of SARS and control groups in SARS ICU with respect to ventilatory parameters, medications, and complications
| Variable | Patients with confirmed SARS (n = 14) | Patients without confirmed SARS (n = 36) | P |
|---|---|---|---|
| Mechanical ventilation | |||
| Duration of ventilator (d) | 28.8 ± 39.8 | 22.5 ± 29.2 | .624 |
| Highest PEEP (cm H2O) | 9.3 ± 3.0 | 7.7 ± 3.9 | .042 |
| Pao2/Fio2 on admission | 216 ± 140 | 287 ± 132 | .063 |
| Lowest Pao2/Fio2 | 119 ± 116 | 220 ± 137 | .007 |
| Highest PaCO2 | 64.7 ± 21.3 | 51.4 ± 18.1 | .069 |
| Medications | |||
| Corticosteroids | 12 (85.7) | 14 (38.9) | .004 |
| Ribavirin | 7 (50) | 5 (13.9) | .023 |
| IVIG | 6 (42.9) | 5 (13.9) | .052 |
| Antibiotics | 12 (85.7) | 29 (80.6) | 1.000 |
| Complications | |||
| Pneumothorax | 2 (14.3) | 3 (8.3) | .611 |
| Self-extubation | 2 (14.3) | 1 (2.8) | .186 |
| Acute renal failure requiring hemodialysis | 1 (7.1) | 1 (2.8) | .486 |
Data are presented as mean ± SD or n (%).